Ibogaine and 5-MeO-DMT Linked to Adverse Health Effects

A new study found users of these substances reported higher rates of cardiac symptoms and suicidal thoughts.

Updated on Oct. 1, 2026 in Substance Abuse

Ibogaine and 5-MeO-DMT Linked to Adverse Health Effects

Live Poll

Should the government implement stricter public health surveillance of recreational substance use?

A cross-sectional study of 1,964 adults revealed that users of ibogaine and 5-MeO-DMT experienced significantly higher rates of adverse health events compared to users of psilocybin, LSD, or MDMA. The findings highlight concerning trends in physical and mental health outcomes associated with these specific substances.

Why it matters

Understanding the potential health risks of hallucinogens is critical as usage trends evolve, particularly for substances that show high levels of self-reported adverse events. This research provides a data-driven look at the consequences individuals face when using these substances.

Researchers observed that 59.3% of ibogaine users reported thoughts of suicide, while 44.2% experienced heart palpitations or chest pain. Comparatively, healthcare utilization attributed to substance use reached 74.2% among ibogaine users.

The players

JAMA Network Open

This is a monthly open-access medical journal published by the American Medical Association that covers all aspects of biomedical research and clinical practice.

The details

Data for the study were collected through the 2025 National Survey Investigating Hallucinogenic Trends. Participants reported health changes and healthcare interactions attributed to their substance use over the past year.

Timeline

  1. Data collection for the survey was conducted in 2025.

  2. The study was published in JAMA Network Open on September 29, 2026.

Health Landscape

This research follows a growing pattern of investigations into the 2025 National Survey Investigating Hallucinogenic Trends, which aims to provide empirical data on the shifting usage of psychoactive substances. By documenting specific adverse effects, the study marks a significant step in characterizing the safety profiles of substances beyond traditional psychedelics.

The study suggests that individuals using ibogaine or 5-MeO-DMT should be aware of the high potential for cardiac distress and mental health challenges. Readers experiencing symptoms such as chest pain or persistent thoughts of self-harm should prioritize seeking professional medical guidance.

The takeaway

This study serves as a warning that not all substances categorized under the broad umbrella of hallucinogens carry the same risk profiles for physical or psychological harm. Users and healthcare providers must account for the high frequency of adverse effects specifically associated with ibogaine and 5-MeO-DMT.

Further reading

For more on evolving research in this field, see the Substance Abuse section.

Source note: This article includes information reported by Medscape.

Live Poll

Should the government implement stricter public health surveillance of recreational substance use?